Novartis Oncology Brand and Communications Director Salaries in Boulder
The average Novartis Oncology Brand and Communications Director in Boulder earns an estimated $184,964 annually, which includes an estimated base salary of $151,303 with a $33,661 bonus. Novartis Oncology's Brand and Communications Director compensation is $20,057 more than the US average for a Brand and Communications Director. Brand and Communications Director salaries at Novartis Oncology in Boulder can range from $70,500 - $430,000.
In Boulder, The HR Department at Novartis Oncology earns $11,239 more on average than the Marketing Department.
Last updated 3 years ago.
- $151,303
- avg. base
- $33,661
- avg. bonus
Brand and Communications Director Salaries at Novartis Oncology
In Boulder, Brand and Communications Directors earn $1,744 more than Directors of HR.
Compensation at Novartis Oncology by Department
In Boulder, The HR Department averages $11,239 more than the Marketing Department, and $5,055 less than the Legal Department
Brand and Communications Director Compensation by Gender (All Companies)
The average female Brand and Communications Director at companies similar size to Novartis Oncology reported making $181,208, while the average male Brand and Communications Director at similar sized companies reported making $186,115.
Brand and Communications Director Compensation by Ethnicity (All Companies)
The average African American/Black Brand and Communications Director at companies similar size to Novartis Oncology reported making $201,250, while the average Hispanic or Latino Brand and Communications Director at similar sized companies reported making $143,063.
How Brand and Communications Directors at Novartis Oncology Rate Their Compensation
The majority of Brand and Communications Directors at Novartis Oncology believe they're not compensated fairly. 100% of Brand and Communications Directors at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
